End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9.78 CNY | +1.24% |
|
-4.77% | -38.10% |
16/05 | Olymvax Biopharma's Flu Vaccine Gets China Nod for Clinical Trials | MT |
25/04 | Chengdu Olymvax Biopharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-38.10% | 541M | |
+2.14% | 94.45B | |
-1.71% | 38.9B | |
-12.83% | 32.56B | |
-12.14% | 15.98B | |
-0.68% | 13.82B | |
-12.63% | 11.34B | |
+163.45% | 9.81B | |
-53.23% | 9.67B | |
+3.52% | 8.91B |
- Stock Market
- Equities
- 688319 Stock
- News Chengdu Olymvax Biopharmaceuticals Inc.
- Olymvax Biopharmaceuticals Grants Keyuan Xinhai Marketing Rights for Meningococcal Vaccines